Whitehawk Therapeutics (WHWK) Intangibles (2021 - 2022)

Whitehawk Therapeutics' (WHWK) quarterly Intangibles came in at $3.7 million in Q1 2022, down 1.78% on a QoQ basis from $3.8 million in Q4 2021.

Whitehawk Therapeutics (WHWK) Intangibles (2021 - 2022) Analysis & Trends

Whitehawk Therapeutics (WHWK) has 2 years of Intangibles data on file, last reported at $3.7 million in Q1 2022.

On a quarterly basis, Intangibles changed N/A year-over-year to $3.7 million in Q1 2022; TTM through Mar 2022 was $3.7 million, a N/A change from a year earlier, with the FY2021 full-year figure at $3.8 million, changed N/A from the prior year.
Intangibles for Q1 2022 stood at $3.7 million, down from $3.8 million in the prior quarter.
Over the last five years, Intangibles for WHWK reached as high as $3.9 million in Q3 2021 and fell as low as $3.7 million in Q1 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Intangibles (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	16.97 Mn
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	11,640.44
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	61.68 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	2.92 Mn
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	418.50 Mn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	1.29 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	266.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	55.80 Mn
10	Whitehawk Therapeutics	34.18 Mn	34.18 Mn	-	-

Download Data